SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001479290-22-000063
Filing Date
2022-05-06
Accepted
2022-05-06 18:19:36
Documents
1
Period of Report
2022-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165187555569277.html 4  
1 FORM 4 wf-form4_165187555569277.xml 4 5895
  Complete submission text file 0001479290-22-000063.txt   7302
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Nolet Chris (Reporting) CIK: 0001782814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 22902713